drugset / Trial / NCT00487422

Efficacy and Safety Study of Prucalopride for the Treatment of Elderly Patients With Chronic Constipation

NCT00487422

Phase 3 Completed 303 enrolled Movetis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of chronic constipation in elderly patients. Hypothesis: Prucalopride 2 mg and 4 mg given once daily for 12 weeks is superior to placebo for the treatment of patients with chronic constipation and is well tolerated in those patients

Timeline

Start
1998-10
Primary completion
1999-09
Completion
1999-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prucalopride Small molecule 1 mg
Comparator Prucalopride Small molecule 2 mg
Comparator Prucalopride Small molecule 4 mg

Indications